Ahmad Ghasemi1, Seyed Isaac Hashemy2, Mohsen Azimi-Nezhad3, Alireza Dehghani4, Jafar Saeidi5, Mahnaz Mohtashami6. 1. Non-communicable Disease Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran. Electronic address: Ghasemia2@nums.ac.ir. 2. Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: HashemyI@mums.ac.ir. 3. Non-communicable Disease Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran; UMR INSERM U 1122, IGE-PCV, Interactions Gène-Environment en Physiopathologie Cardiovascular Université de Lorraine, France. 4. Institute of Biochemistry and Molecular Biology, University of Bonn, Bonn, Germany. 5. Department of Physiology, School of Basic Science, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran. 6. Department of Biology, School of Basic Science, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.
Abstract
BACKGROUND: Multiple studies have revealed a direct correlation between obesity and the development of multiple comorbidities, including metabolic diseases, cardiovascular disorders, chronic inflammatory disease, and cancers. However, the molecular mechanism underlying the link between obesity and the progression of these diseases is not completely understood. Adipokines are factors that are secreted by adipocytes and play a key role in whole body homeostasis. Collaboratively, miRNAs are suggested to have key functions in the development of obesity and obesity-related disorders. Based on recently emerging evidence, obesity leads to the dysregulation of both adipokines and obesity-related miRNAs. In the present study, we described the correlations between obesity and its related diseases that are mediated by the mutual regulatory effects of adipokines and miRNAs. METHODS: We reviewed current knowledge of the modulatory effects of adipokines on miRNAs activity and their relevant functions in pathological conditions and vice versa. RESULTS: Our research reveals the ability of adipokines and miRNAs to control the expression and activity of the other class of molecules, and their effects on obesity-related diseases. CONCLUSIONS: This study may help researchers develop a roadmap for future investigations and provide opportunities to develop new therapeutic and diagnostic methods for treating obesity-related diseases.
BACKGROUND: Multiple studies have revealed a direct correlation between obesity and the development of multiple comorbidities, including metabolic diseases, cardiovascular disorders, chronic inflammatory disease, and cancers. However, the molecular mechanism underlying the link between obesity and the progression of these diseases is not completely understood. Adipokines are factors that are secreted by adipocytes and play a key role in whole body homeostasis. Collaboratively, miRNAs are suggested to have key functions in the development of obesity and obesity-related disorders. Based on recently emerging evidence, obesity leads to the dysregulation of both adipokines and obesity-related miRNAs. In the present study, we described the correlations between obesity and its related diseases that are mediated by the mutual regulatory effects of adipokines and miRNAs. METHODS: We reviewed current knowledge of the modulatory effects of adipokines on miRNAs activity and their relevant functions in pathological conditions and vice versa. RESULTS: Our research reveals the ability of adipokines and miRNAs to control the expression and activity of the other class of molecules, and their effects on obesity-related diseases. CONCLUSIONS: This study may help researchers develop a roadmap for future investigations and provide opportunities to develop new therapeutic and diagnostic methods for treating obesity-related diseases.
Authors: Justyna Strycharz; Adam Wróblewski; Andrzej Zieleniak; Ewa Świderska; Tomasz Matyjas; Monika Rucińska; Lech Pomorski; Piotr Czarny; Janusz Szemraj; Józef Drzewoski; Agnieszka Śliwińska Journal: Antioxidants (Basel) Date: 2021-01-12